C75 Category · further specificity required Malignant neoplasm of other endocrine glands and related structures
ICD-10-CM C75 identifies “Malignant neoplasm of other endocrine glands and related structures” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 2: Neoplasms
Code-level instructions
Excludes 19
- malignant carcinoid tumors (C7A.0-)
- malignant neoplasm of adrenal gland (C74.-)
- malignant neoplasm of endocrine pancreas (C25.4)
- malignant neoplasm of islets of Langerhans (C25.4)
- malignant neoplasm of ovary (C56.-)
- malignant neoplasm of testis (C62.-)
- malignant neoplasm of thymus (C37)
- malignant neoplasm of thyroid gland (C73)
- malignant neuroendocrine tumors (C7A.-)
Inherited instructions
Chapters 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
More specific codes
C75.0Malignant neoplasm of parathyroid glandBillable / specificC75.1Malignant neoplasm of pituitary glandBillable / specificC75.2Malignant neoplasm of craniopharyngeal ductBillable / specificC75.3Malignant neoplasm of pineal glandBillable / specificC75.4Malignant neoplasm of carotid bodyBillable / specificC75.5Malignant neoplasm of aortic body and other paragangliaBillable / specificC75.8Malignant neoplasm with pluriglandular involvement, unspecifiedBillable / specificC75.9Malignant neoplasm of endocrine gland, unspecifiedBillable / specificOfficial index references
References from other codes (3)
Code first · , if applicable, any current malignant neoplasm (C00-C75, C81-C96)
Inclusion terms · Conditions classifiable to C00-C14, C40-C49, C69-C75, C7A.098, C76-C79
Inclusion terms · Conditions classifiable to C73-C75
History
Code history
No recorded change since first observation
Effective from
- First observed
Malignant neoplasm of other endocrine glands and related structures
Category — select a more specific code
CDC/NCHS · FY2016All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.